Organization Overview
Historical Acquisition Tree
Alternative names
Key: Lambda Therapeutic Research Ltd (0) Acquired (1)
Key: Lambda Therapeutic Research Ltd (2) Acquired (12)
Key: Lambda Therapeutic Research Ltd (0) Acquired (3)
Key: Lambda Therapeutic Research Ltd (12) Acquired (31)
bleomycin (blenoxane) (1 trial)
bupropion (wellbutrin) (2 trials)
carbidopa (sinemet) (2 trials)
cetirizine (zyrtec) (4 trials)
cevimeline hydrochloride (evoxac) (2 trials)
clarithromycin (biaxin) (2 trials)
clobetasol (dermovate) (2 trials)
clopidogrel (plavix) (2 trials)
doxorubicin (Doxil) (2 trials)
filgrastim (neupogen) (2 trials)
finasteride (Proscar) (4 trials)
glimepiride (amaryl) (2 trials)
glipizide (glucotrol) (1 trial)
hydrochlorothiazide (esidrix) (1 trial)
isotretinoin (accutane) (1 trial)
leflunomide (arava) (3 trials)
metronidazole (flagyl) (1 trial)
moexipril (univasc) (2 trials)
moxifloxacin (avelox) (1 trial)
mycophenolate (myfortic) (5 trials)
olanzapine (zyprexa) (2 trials)
ondansetron (zofran) (4 trials)
oxymorphone (opana) (3 trials)
Key: Lambda Therapeutic Research Ltd (0) Acquired (5)
Breast Neoplasms (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 1)
Disease (Phase 3)
Malnutrition (Phase 1)
Ovarian Neoplasms (Phase 1)
Parkinson Disease (Phase 1)
Triple Negative Breast Neoplasms (Phase 3)